Quick Answer
Tyra Biosciences, Inc. reported Total Assets of $282.61 million for fiscal year 2025.
Tyra Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $282.61M | -22.3% |
| 2024 | $363.56M | +61.0% |
| 2023 | $225.86M | -15.1% |
| 2022 | $266.18M | -13.2% |
| 2021 | $306.70M | +1815.6% |
| 2020 | $16.01M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $301.85M | -20.7% | -6.1% |
| June 30, 2025 | $321.50M | -18.1% | -6.4% |
| March 31, 2025 | $343.48M | -15.1% | -5.5% |
| December 31, 2024 | $363.56M | +61.0% | -4.5% |
| September 30, 2024 | $380.59M | +59.7% | -3.0% |
| June 30, 2024 | $392.46M | +57.0% | -3.0% |
| March 31, 2024 | $404.74M | +58.7% | +79.2% |
| December 31, 2023 | $225.86M | -15.1% | -5.2% |
- Tyra Biosciences, Inc. showed a decrease of -22.3% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Tyra Biosciences, Inc.’s total assets has grown by 1665.1% (from $16.01 million to $282.61 million).
- The most recent figure is from Tyra Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: